Evidence map›Paper›PMID 21493686›Full record

ArticleNucleic acids research2011

Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual.

Pedro A F Galante, Raphael B Parmigiani, Qi Zhao, Otávia L Caballero, Jorge E de Souza, Fábio C P Navarro, Alexandra L Gerber, Marisa F Nicolás, Anna Christina M Salim, Ana Paula M Silva and 22 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 3 institutions in 1 country.

Pedro A F GalanteLudwig Institute for Cancer Research, São Paulo Branch at Hospital Alemão Oswaldo Cruz, São Paulo 01323-903, Brazil.
Raphael B Parmigiani
Qi Zhao
Otávia L Caballero
Jorge E de Souza
Fábio C P Navarro
Alexandra L Gerber
Marisa F Nicolás
Anna Christina M Salim
Ana Paula M Silva
Lee Edsall
Sylvie Devalle
Luiz G Almeida
Zhen Ye
Samantha Kuan
Daniel G Pinheiro
Israel Tojal
Renato G Pedigoni
Rodrigo G M A de Sousa
Thiago Y K Oliveira
Marcelo G de Paula
Lucila Ohno-Machado
Ewen F Kirkness
Samuel Levy
Wilson A da Silva
Ana Tereza R Vasconcelos
Bing Ren
Marco Antonio Zago
Robert L Strausberg
Andrew J G Simpson
Sandro J de Souza
Anamaria A Camargo
Johns Hopkins University · USJ. Craig Venter Institute · USUniversity of California, San Diego · US

Funding

Global Health Informatics for Cancer ResearchD43TW007015 · FIC · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OHNO-MACHADO, LUCILA · 2004 to 2013
$2.2M
FIC NIH HHS D43 TW007015FIC NIH HHS D43TW007015
6 · The paper itself

Abstract

Although patterns of somatic alterations have been reported for tumor genomes, little is known on how they compare with alterations present in non-tumor genomes. A comparison of the two would be crucial to better characterize the genetic alterations driving tumorigenesis. We sequenced the genomes of a lymphoblastoid (HCC1954BL) and a breast tumor (HCC1954) cell line derived from the same patient and compared the somatic alterations present in both. The lymphoblastoid genome presents a comparable number and similar spectrum of nucleotide substitutions to that found in the tumor genome. However, a significant difference in the ratio of non-synonymous to synonymous substitutions was observed between both genomes (P = 0.031). Protein-protein interaction analysis revealed that mutations in the tumor genome preferentially affect hub-genes (P = 0.0017) and are co-selected to present synergistic functions (P < 0.0001). KEGG analysis showed that in the tumor genome most mutated genes were organized into signaling pathways related to tumorigenesis. No such organization or synergy was observed in the lymphoblastoid genome. Our results indicate that endogenous mutagens and replication errors can generate the overall number of mutations required to drive tumorigenesis and that it is the combination rather than the frequency of mutations that is crucial to complete tumorigenic transformation.

Indexed as

Genetic VariationGenome, HumanBreast NeoplasmsCell Line, TransformedCell Line, TumorChromosome AberrationsFemaleHumansLymphocytesMiddle AgedMutationPoint MutationProtein Interaction MappingSequence Analysis, DNA

Identifiers

PMID21493686
PMCPMC3152357
OpenAlexW1974773495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.